Cargando…
Antisense Gene Silencing: Therapy for Neurodegenerative Disorders?
Since the first reports that double-stranded RNAs can efficiently silence gene expression in C. elegans, the technology of RNA interference (RNAi) has been intensively exploited as an experimental tool to study gene function. With the subsequent discovery that RNAi could also be applied to mammalian...
Autores principales: | Nielsen, Troels T., Nielsen, Jørgen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924827/ https://www.ncbi.nlm.nih.gov/pubmed/24705213 http://dx.doi.org/10.3390/genes4030457 |
Ejemplares similares
-
Silencing Antibiotic Resistance with Antisense Oligonucleotides
por: Jani, Saumya, et al.
Publicado: (2021) -
Silencing genes in the kidney: antisense or RNA interference?
por: Wang, Jia-Hui, et al.
Publicado: (2008) -
Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases
por: Helm, Jacob, et al.
Publicado: (2022) -
A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells
por: Castanotto, Daniela, et al.
Publicado: (2015) -
Advances of Antisense Oligonucleotide Technology in the Treatment of Hereditary Neurodegenerative Diseases
por: Lin, Mengsi, et al.
Publicado: (2021)